Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Inhaled Corticosteroid Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Beclomethasone Dipropionate
  • 1.3.3 Budesonide
  • 1.3.4 Fluticasone Inhaler Powder
  • 1.3.5 Mometasone
  • 1.3.6 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Inhaled Corticosteroid Market Share by Application (2019-2025)
  • 1.4.2 Hospitals
  • 1.4.3 Clinics
  • 1.4.4 Respiratory Care Centers
  • 1.4.5 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Inhaled Corticosteroid Market Size
  • 2.1.1 Global Inhaled Corticosteroid Revenue 2014-2025
  • 2.1.2 Global Inhaled Corticosteroid Sales 2014-2025
• 2.2 Inhaled Corticosteroid Growth Rate by Regions
  • 2.2.1 Global Inhaled Corticosteroid Sales by Regions 2014-2019
  • 2.2.2 Global Inhaled Corticosteroid Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Inhaled Corticosteroid Sales by Manufacturers
  • 3.1.1 Inhaled Corticosteroid Sales by Manufacturers 2014-2019
  • 3.1.2 Inhaled Corticosteroid Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Inhaled Corticosteroid Revenue by Manufacturers (2014-2019)
  • 3.2.2 Inhaled Corticosteroid Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Inhaled Corticosteroid Market Concentration Ratio (CR5 and HHI)
• 3.3 Inhaled Corticosteroid Price by Manufacturers
• 3.4 Key Manufacturers Inhaled Corticosteroid Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Inhaled Corticosteroid Market
• 3.6 Key Manufacturers Inhaled Corticosteroid Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Beclomethasone Dipropionate Sales and Revenue (2014-2019)
  • 4.1.2 Budesonide Sales and Revenue (2014-2019)
  • 4.1.3 Fluticasone Inhaler Powder Sales and Revenue (2014-2019)
  • 4.1.4 Mometasone Sales and Revenue (2014-2019)
  • 4.1.5 Others Sales and Revenue (2014-2019)
• 4.2 Global Inhaled Corticosteroid Sales Market Share by Type
• 4.3 Global Inhaled Corticosteroid Revenue Market Share by Type
• 4.4 Inhaled Corticosteroid Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Inhaled Corticosteroid Sales by Application

6 United States

• 6.1 United States Inhaled Corticosteroid Breakdown Data by Company
• 6.2 United States Inhaled Corticosteroid Breakdown Data by Type
• 6.3 United States Inhaled Corticosteroid Breakdown Data by Application

7 European Union

• 7.1 European Union Inhaled Corticosteroid Breakdown Data by Company
• 7.2 European Union Inhaled Corticosteroid Breakdown Data by Type
• 7.3 European Union Inhaled Corticosteroid Breakdown Data by Application

8 China

• 8.1 China Inhaled Corticosteroid Breakdown Data by Company
• 8.2 China Inhaled Corticosteroid Breakdown Data by Type
• 8.3 China Inhaled Corticosteroid Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Inhaled Corticosteroid Breakdown Data by Company
• 9.2 Rest of World Inhaled Corticosteroid Breakdown Data by Type
• 9.3 Rest of World Inhaled Corticosteroid Breakdown Data by Application
• 9.4 Rest of World Inhaled Corticosteroid Breakdown Data by Countries
  • 9.4.1 Rest of World Inhaled Corticosteroid Sales by Countries
  • 9.4.2 Rest of World Inhaled Corticosteroid Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Sumitomo
  • 10.1.1 Sumitomo Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Inhaled Corticosteroid
  • 10.1.4 Inhaled Corticosteroid Product Introduction
  • 10.1.5 Sumitomo Recent Development
• 10.2 Pfizer
  • 10.2.1 Pfizer Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Inhaled Corticosteroid
  • 10.2.4 Inhaled Corticosteroid Product Introduction
  • 10.2.5 Pfizer Recent Development
• 10.3 Novartis
  • 10.3.1 Novartis Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Inhaled Corticosteroid
  • 10.3.4 Inhaled Corticosteroid Product Introduction
  • 10.3.5 Novartis Recent Development
• 10.4 Merck
  • 10.4.1 Merck Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Inhaled Corticosteroid
  • 10.4.4 Inhaled Corticosteroid Product Introduction
  • 10.4.5 Merck Recent Development
• 10.5 Sanofi
  • 10.5.1 Sanofi Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Inhaled Corticosteroid
  • 10.5.4 Inhaled Corticosteroid Product Introduction
  • 10.5.5 Sanofi Recent Development
• 10.6 Johnson and Johnson
  • 10.6.1 Johnson and Johnson Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Inhaled Corticosteroid
  • 10.6.4 Inhaled Corticosteroid Product Introduction
  • 10.6.5 Johnson and Johnson Recent Development
• 10.7 GSK
  • 10.7.1 GSK Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Inhaled Corticosteroid
  • 10.7.4 Inhaled Corticosteroid Product Introduction
  • 10.7.5 GSK Recent Development
• 10.8 AstraZeneca
  • 10.8.1 AstraZeneca Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Inhaled Corticosteroid
  • 10.8.4 Inhaled Corticosteroid Product Introduction
  • 10.8.5 AstraZeneca Recent Development
• 10.9 Teijin
  • 10.9.1 Teijin Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Inhaled Corticosteroid
  • 10.9.4 Inhaled Corticosteroid Product Introduction
  • 10.9.5 Teijin Recent Development
• 10.10 Glaxo's Advair
  • 10.10.1 Glaxo's Advair Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Inhaled Corticosteroid
  • 10.10.4 Inhaled Corticosteroid Product Introduction
  • 10.10.5 Glaxo's Advair Recent Development
• 10.11 Amgen
• 10.12 Kos Pharmaceutical
• 10.13 Teva Pharmaceutical

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Inhaled Corticosteroid Sales Channels
  • 11.2.2 Inhaled Corticosteroid Distributors
• 11.3 Inhaled Corticosteroid Customers

12 Market Forecast

• 12.1 Global Inhaled Corticosteroid Sales and Revenue Forecast 2019-2025
• 12.2 Global Inhaled Corticosteroid Sales Forecast by Type
• 12.3 Global Inhaled Corticosteroid Sales Forecast by Application
• 12.4 Inhaled Corticosteroid Forecast by Regions
  • 12.4.1 Global Inhaled Corticosteroid Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Inhaled Corticosteroid Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Asthma is a disease of the entire respiratory tract, including large, intermediate and small airways. Asthma led to inflammation and obstruction of respiratory tract. Patients have various treatment options for asthma, particularly for young and elderly patients. Hence this has led to significant interest on the part of the inhaler device which is easy to use. Inhaled corticosteroid is the most commonly used tool for the treatment of asthma. As with increasing pollution and increasing incidences of asthma, many companies are engaged in the development of new inhaler corticosteroid devices.
In terms of market value, North America will dominate the inhaler corticosteroid device market during the forecast period. Increasing incidences of life-threatening illness such as chronic obstructive pulmonary disease, asthma and many more are some of the factors which are responsible for the growth of the market during the forecast period.
In 2019, the market size of Inhaled Corticosteroid is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Inhaled Corticosteroid.

This report studies the global market size of Inhaled Corticosteroid, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Inhaled Corticosteroid sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Sumitomo
Pfizer
Novartis
Merck
Sanofi
Johnson and Johnson
GSK
AstraZeneca
Teijin
Glaxo's Advair
Amgen
Kos Pharmaceutical
Teva Pharmaceutical

Market Segment by Product Type
Beclomethasone Dipropionate
Budesonide
Fluticasone Inhaler Powder
Mometasone
Others

Market Segment by Application
Hospitals
Clinics
Respiratory Care Centers
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Inhaled Corticosteroid status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Inhaled Corticosteroid manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Inhaled Corticosteroid are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025